Matthews v. Cresco Labs, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJuly 11, 2025
Docket1:25-cv-01928
StatusUnknown

This text of Matthews v. Cresco Labs, Inc. (Matthews v. Cresco Labs, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matthews v. Cresco Labs, Inc., (N.D. Ill. 2025).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

JOSH MATTHEWS, on behalf of himself and all others similarly situated,

Plaintiff, No. 25 CV 1928

v. Judge Georgia N. Alexakis

CRESCO LABS, INC.; CRESCO LABS, LLC; CRESCO U.S. CORP.; CRESCO EDIBLES, LLC; TSC CRESCO, LLC; CRESCO LABS JOLIET, LLC; CRESCO LABS KANKAKEE, LLC; CRESCO LABS LOGAN, LLC, CRESCO LABS NOTES ISSUER, LLC.

Defendants.

MEMORANDUM OPINION AND ORDER

On April 21, 2024, plaintiff John Matthews purchased a vapable cannabis oil cartridge from an Illinois cannabis dispensary. Matthews then sued the manufacturer Cresco Labs, LLC, and related business entities (hereafter “Cresco”) in Illinois state court, alleging that because the cartridge was not compliant with the Illinois Cannabis Act, Cresco had engaged in deceptive trade practices and consumer fraud. [1-1]. Cresco then removed to federal court under the Class Action Fairness Act (“CAFA”). [1]; 28 U.S.C. § 1332(d). Matthews now moves for remand or, in the alternative, limited discovery to determine if the case falls into one of the statutory CAFA exceptions. [20]. For the following reasons, the motion to remand is denied but the motion for limited discovery is granted. I. Legal Standards Because federal courts are courts of limited jurisdiction, the burden of establishing jurisdiction rests upon the party asserting it. Kokkonen v. Guardian Life Ins. Co. of America, 511 U.S. 375, 377 (1997). Once a removing party proves the

federal court has subject-matter jurisdiction, the burden shifts to the party opposing removal to prove that an “express exception to removability” applies. Hart v. FedEx Ground Package System, Inc., 457 F.3d 675, 679–80 (7th Cir. 2006). II. Background The Court credits the following allegations from the complaint as true for purposes of resolving the instant motion. On April 21, 2024, Matthews, an adult citizen of Illinois, purchased a Cresco High Supply Space Fruit 500-milligram vapable

cannabis oil cartridge from a cannabis dispensary in Oak Lawn, Illinois. [1-1] ¶¶ 16, 113–14. Vapable cannabis oil is a cannabis product that is “ubiquitous and readily available at most dispensaries.” Id. ¶ 42. A vapable cannabis oil cartridge like that purchased by Matthews is inserted in a battery—also known as a “vape pen”—which heats the cannabis oil until it is vaporized and can be inhaled by the user. Id. ¶ 47. The purchase, possession, and use of certain cannabis products is legal under

the Illinois Cannabis Act. See 410 ILCS 705/10-5. But the quantity of cannabis products that an individual can possess is restricted by type. 410 ILCS 705/10-10. As relevant here, those limits include “no more than 500 milligrams of THC contained in cannabis-infused product,” 410 ILCS 705/10-10(a)(2), and “5 grams of cannabis concentrate,” 410 ILCS 705/10-10(a)(3).1 A cannabis-infused product is any “beverage, food, oil, ointment, tincture, topical formulation, or another product containing cannabis or cannabis concentrate that is not intended to be smoked.” 410

ILCS 705/1-10 (emphasis added). Cannabis-infused products cannot be packaged in quantities exceeding 100 milligrams of THC. 410 ILCS 705/55-21(k). Cannabis concentrate is a product “derived from cannabis that is produced by extracting cannabinoids, including tetrahydrocannabinol (THC) … with the intended use of smoking or making a cannabis-infused product.” 410 ILCS 705/1-10 (emphasis added). The Illinois Cannabis Act defines “smoking” as “the inhalation of smoke caused by the combustion of cannabis.” 410 ILCS 705/1-10.

The core of Matthew’s complaint is that while Cresco’s vapable cannabis oil is packaged and marketed as a “cannabis concentrate” subject to the higher 5-gram possession limit, it is in fact a cannabis-infused product subject to the lower limits. [1-1] ¶¶ 93–97. Since the Cannabis Act defines cannabis concentrate as having “an intended use of smoking,” 410 ILCS 705/1-10, and a vape pen creates oil vapor rather than “smoke caused by the combustion of cannabis,” id., Matthews argues that

vapable cannabis oil is not intended for smoking and therefore not cannabis concentrate. [1-1] ¶¶ 61–65. According to Matthews, this misleads and harms consumers in two ways. First, the substantially greater quantity of THC may result in overconsumption, with

1 The limits are reduced for out-of-state purchasers, but the differences are irrelevant to the instant motion. associated negative effects like “psychoactive effects, anxiety attacks, or overwhelming intoxication.” Id. ¶ 104. Second, a consumer who possessed 5 grams of cannabis-infused product exceeds the legal possession limit and may thus

inadvertently find herself out of compliance with Illinois law. Id. ¶¶ 98–103. Matthews sued Cresco in Illinois court on January 14, 2025. [1-1]. In addition to his individual claims, Matthews seeks to bring claims on behalf of “[a]ll persons who … purchased within the State of Illinois any Vapable Oils manufactured, processed, made, labeled, and/or packaged by Defendants.” Id. ¶ 125. Cresco quickly removed to federal court pursuant to the Class Action Fairness Act (“CAFA”), [1], which grants original federal jurisdiction when a proposed class has at least 100

members, the aggregate amount in controversy exceeds $5,000,000, and the class is minimally diverse. 28 U.S.C. § 1322(d)(2). There is no current dispute2 that this case meets these threshold requirements for federal jurisdiction; rather, Matthews now contends that remand is warranted based on three CAFA exceptions: the home-state exception, the local controversy exception, and the discretionary exception. [20] at 6– 11. In the alternative, Matthews moves for limited discovery to determine whether

any of the proposed exceptions are met. Id. 11–14.

2 Matthews initially argued that Cresco had failed to establish minimal diversity, [20] at 4– 6, but at a May 28, 2025 hearing conceded that Cresco’s response, [24-1], sufficiently identified at least one non-Illinois citizen, and does not challenge the amount-in-controversy or class size requirements. III. Analysis A. Motion to Remand Under CAFA’s home-state exception, the Court “shall decline to exercise jurisdiction” over class action cases “when two-thirds or more of the members of all

proposed plaintiff classes in the aggregate, and the primary defendants, are citizens of the State in which the action was originally filed.” 28 U.S.C. § 1332(d)(4)(B). Matthews argues that “it is all but certain that more than two-thirds of the putative class members are Illinois citizens because the class is limited to individuals who purchased Defendants’ Vape Products in the State of Illinois.” [20] at 6.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kokkonen v. Guardian Life Insurance Co. of America
511 U.S. 375 (Supreme Court, 1994)
In Re Sprint Nextel Corp.
593 F.3d 669 (Seventh Circuit, 2010)
Charlotte Phillips v. Wellpoint Incorporated
764 F.3d 662 (Seventh Circuit, 2014)
Hart v. FedEx Ground Package System Inc.
457 F.3d 675 (Seventh Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Matthews v. Cresco Labs, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/matthews-v-cresco-labs-inc-ilnd-2025.